Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.2294
Delayed Data
As of Mar 30
 +0.0044 / +1.96%
Today’s Change
0.21
Today|||52-Week Range
0.42
-8.24%
Year-to-Date
No recent news for Hemispherx Biopharma Inc.

Today’s Trading

Previous close0.23
Today’s open0.23
Day’s range0.22 - 0.23
Volume711,500
Average volume (3 months)1,890,905
Market cap$48.4M
Dividend yield--
Data as of 3:59pm ET, 03/30/2015

Growth & Valuation

Earnings growth (last year)+16.67%
Earnings growth (this year)--
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)-29.58%
P/E ratioNM
Price/Sales295.61
Price/Book1.30

Competitors

 Today’s
change
Today’s
% change
OGXIOncoGenex Pharmaceut...0.000.00%
APDNApplied DNA Sciences...0.000.00%
ACSTAcasti Pharma Inc+0.01+1.78%
MTEXMannatech Inc-0.68-3.56%
Data as of 3:59pm ET, 03/30/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$150.0K
Annual profit (last year)-$16.2M
Net profit margin-10,816.67%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, Chief Executive Officer &
CSO
William A. Carter
Senior Vice President-
Operations
Wayne S. Springate
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account